This is a public record generated listing.
Clinical-Stage Biopharmaceutical Company in California
Listing Information
Attachments
Clinical-Stage Biopharmaceutical Company in California
Price: Not Specified
Other Item Info
Item #: debke_177880
Created: 10/23/2019
Category: Business Property > All Assets or Going Concerns > Pharmaceuticals & Biotechnology
Sale Location: New York, New York
Sale Date: Thu. Dec 5, 2019
Created: 10/23/2019
Category: Business Property > All Assets or Going Concerns > Pharmaceuticals & Biotechnology
Sale Location: New York, New York
Sale Date: Thu. Dec 5, 2019
Seller Info
Kara Coyle
Debtor's Attorney
1000 North King Street
Wilmington, DE 19801
302-571-6600
Debtor's Attorney
1000 North King Street
Wilmington, DE 19801
302-571-6600
Bankruptcy Info
Case #: 1:19-bk-12051
Case Title: Sienna Biopharmaceuticals, Inc.
Court: Delaware Bankruptcy Court
Chapter: 11
View Case Docket
Case Title: Sienna Biopharmaceuticals, Inc.
Court: Delaware Bankruptcy Court
Chapter: 11
View Case Docket
Description
Auction Sale of substantially all of assets of the Sienna Biopharmaceuticals, Inc. This sale also includes of the stock of the seller’s non-debtor subsidiary Creabilis Holdings Limited, which in turn owns Sienna Biopharmaceuticals S.A. (which, as discussed in greater detail in the First Day Declaration, holds certain intellectual property of the seller related to SNA-120), or the assets of the nondebtor subsidiaries, which, for the avoidance of doubt.
Financial Overview
Income and Expenses ($)
months
Revenue/Gross Income:
Total Expenses:
Cash Flow:
Asset and Liability Summary ($)
Receivables:
Inventory:
FF&E:
Real Estate:
Total Assets:
Liabilities to assume:
Additional Details
- Auction Time: 10:00 a.m.
- Sale Hearing Held on December 10, 2019 at 10:30 a.m.
- Bid Deposit: 10% of the proposed purchase price
- Bid Deadline: December 2, 2019
- Last date to respond: December 3, 2019